Nikhil Lalwani - Mar 6, 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Stephen P. Carey
Stock symbol
ANIP
Transactions as of
Mar 6, 2024
Transactions value $
-$4,129,541
Form type
4
Date filed
3/8/2024, 07:25 PM
Previous filing
Mar 1, 2024
Next filing
Mar 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale -$1.9M -29K -6.11% $65.52 445K Mar 6, 2024 Direct F1
transaction ANIP Common Stock Tax liability -$1.14M -17.1K -3.83% $66.71 428K Mar 7, 2024 Direct F2
transaction ANIP Common Stock Sale -$1.09M -16.3K -3.81% $67.13 412K Mar 8, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple trades at prices ranging from $65.00 to $66.01. The price reported above reflects the weighted average sales price.
F2 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported.
F3 The shares were sold in multiple trades at prices ranging from $66.42 to $67.74. The price reported above reflects the weighted average sales price.